Amgen Inc. buy Royal Bank of Canada
Start price
02.05.25
/
50%
€247.25
Target price
02.05.26
€283.33
Performance (%)
21.30%
Price
27.04.26
€290.25
This prediction will end soon
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada currently has a performance of 21.30%. Dividends of €9.66 are taken into consideration when calculating the performance. This prediction currently runs until 02.05.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | -2.306% | -2.306% |
| iShares Core DAX® | -1,42 % | 8,92 % |
| iShares Nasdaq 100 | 3,27 % | 16,28 % |
| iShares Nikkei 225® | 1,75 % | 16,24 % |
| iShares S&P 500 | 1,45 % | 10,91 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target lowered by analysts at Royal Bank of Canada from $324.00 to $320.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat